ARIS Trials: field-trial software with reproducible multi-site statistics, open to pilots and licensing

What it is: ARIS Trials is field-trial software for crop-protection, biologicals, seed and agronomy R&D, with a web app and an offline phone app. It covers the whole trial: randomized layouts (RCBD, CRD, Latin square, split-plot) and field maps; offline data capture with range checks; ANOVA with mean separation and compact letters, % vs check, rank tests, repeated ratings and AUDPC, dose-response, power planning and combined analysis across sites; and a report builder with a full audit trail.

Why it matters: multi-location trials are often run by many sites, contract cooperators and research partners, each delivering data in its own format. With ARIS every location runs the same protocol and delivers data and readouts in one verifiable format, so decisions come sooner with less rework.

Proof to date: ARIS is live at app.aristrials.com. In October 2026 validation, R independently reproduced 128,568 of 128,568 ARIS results across 167 trial scenarios; SciPy/statsmodels re-derived 105 of 105 reference values; 132 of 132 reference tests passed. Every analysis exports as an R script that reproduces it and confirms the numbers match, so any statistician can check the results. Data integrity is built in: audit trail with reason-for-change, two-factor sign-in, blinded treatment codes and locked records. There are no field pilot results yet.

How a partnership works: a one-season pilot on one trial series, run alongside the current process, with success measures agreed at kickoff (days from final assessment to readout, analyst hours per trial, data errors caught). ARIS imports CSV and Excel exports from existing trial tools, so no system integration is needed. Partners keep ownership of all trial data, and a data agreement comes before any data is entered. If the pilot succeeds, the next step is a license for the program and its trial network.

ARIS Trials LLC is an independent US company.